Author: Amara Diallo

Amara Diallo covers the critical intersection of biotech innovation, health economics, and public policy. She provides in-depth analysis on drug pricing, insurance reimbursement models, and legislative shifts that impact patient access to novel therapies. Her reporting ensures that readers understand not just the science behind new treatments, but the economic realities of bringing them to market.